Focusing on risks, not hazards, can pave the way for smaller enzyme producers
Regulations and bureaucracy within the European Union can be a big burden when introducing enzyme-based products to the market. One of the world’s largest enzyme producers think focus should be on potential risks instead of hazards in the regulatory framework. This might help projects like the recently finished OXIPRO. The Horizon EU funded …
Focusing on risks, not hazards, can pave the way for smaller enzyme producers Read More »









